Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06237621 · ClinicalTrials.gov registry record
Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment
A clinical trial of Peripheral Arterial Disease, sponsored by Kent Imaging.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06237621 is a study of Peripheral Arterial Disease that is actively recruiting participants, run by Kent Imaging. The registered enrollment target is 150 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06237621, a study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Kent Imaging.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical assessments.
Conditions Studied
Interventions
- DEVICE SnapshotNIR imaging
Study Locations (1)
Texas
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06237621
The ClinicalTrials.gov registry entry for NCT06237621 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The listed sponsor is Kent Imaging, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which SnapshotNIR imaging is the first listed.
NCT06237621 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06237621 about?
NCT06237621 is a clinical study titled "Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment". The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical assessments.
What is the current status of trial NCT06237621?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-02-12. Estimated completion is 2025-06.
What conditions does trial NCT06237621 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT06237621?
The interventions under investigation include: SnapshotNIR imaging (DEVICE).
Who is sponsoring clinical trial NCT06237621?
This trial is sponsored by Kent Imaging, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06237621 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.